SEC Form 4 · accession 0001179110-15-013794
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Rutherford Carter
Officer — EVP Commercial Ops
Period of report
Oct 1, 2015
Accepted (ET)
Oct 5, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2015 | M | 180 | $26.99 | D | 48,963 | D | |
| Common Stock | Oct 1, 2015 | M | 1,820 | $40.56 | D | 50,783 | D | |
| Common Stock | Oct 1, 2015 | S | 2,000 | $98.59 | D | 48,783 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $26.99 | Oct 1, 2015 | M | 180 | D | — | Jul 30, 2018 | Common Stock | 180 | 4,507 | D |
| Non-Qualified Stock Option (right to buy)F3 | $40.56 | Oct 1, 2015 | M | 1,820 | D | — | Feb 1, 2023 | Common Stock | 1,820 | 12,071 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.